Meta-analysis of the Portfolio Dietary Pattern and Cardiometabolic Risk
Effect of a Portfolio Dietary Pattern on Cardiometabolic Risk: A Systematic Review and Meta-analysis of Controlled Trials
1 other identifier
observational
1
1 country
1
Brief Summary
The European Association for the Study of Diabetes (EASD) guidelines have not made any specific recommendations regarding the Portfolio diet, a dietary pattern that includes nuts, viscous fibre, plant protein, and plant sterols. To update the recommendations, the Diabetes and Nutrition Study Group (DNSG) of the EASD commissioned a systematic review and meta-analysis using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to summarize the available evidence from controlled trials of the effect of the Portfolio dietary pattern on LDL-cholesterol (LDL-C) and other established cardiometabolic risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 8, 2018
CompletedFirst Posted
Study publicly available on registry
May 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedMay 23, 2018
May 1, 2018
7 months
May 8, 2018
May 21, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood lipids - LDL-C
Up to 20 years
Secondary Outcomes (13)
Blood lipids - Total-C
Up to 20 years
Blood lipids - HDL-C
Up to 20 years
Blood lipids - non-HDL-C
Up to 20 years
Blood lipids - triglycerides
Up to 20 years
Blood lipids - Apolipoprotein B (apo B)
Up to 20 years
- +8 more secondary outcomes
Study Arms (2)
Intervention
A Portfolio Dietary Pattern involving a combination of 4 cholesterol lowering foods, namely: plant sterols, viscous fibre, plant protein, and nuts.
Control
A National Cholesterol Education Program (NCEP) based diet, a diet low in saturated fat and cholesterol.
Interventions
Portfolio Dietary Pattern consisting of 4 food components, including: 1. plant sterols (sterol-enriched margarine or supplement) 2. viscous soluble fibres (oats, barley, psyllium, eggplant, okra, etc) 3. plant protein (soy products and pulses), and 4. nuts (tree nuts and peanuts)
Eligibility Criteria
All individuals, both children and adults, regardless of health status.
You may qualify if:
- Trials in humans
- Randomized and non-randomized controlled trials
- Assessment of the portfolio dietary pattern in comparison to caloric- and macronutrient-matched diets that were not intended to provide components of the portfolio dietary pattern
- Diet duration ≥ 4 week
- Viable outcome data with ≥ 1 outcome of interest
You may not qualify if:
- Non-human trials
- Observational studies
- Lack of suitable comparator diet
- Diet duration \<4 weeks
- No viable outcome data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital
Toronto, Ontario, M5C 2T2, Canada
Related Publications (5)
Jenkins DJ, Kendall CW, Marchie A, Faulkner D, Vidgen E, Lapsley KG, Trautwein EA, Parker TL, Josse RG, Leiter LA, Connelly PW. The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism. 2003 Nov;52(11):1478-83. doi: 10.1016/s0026-0495(03)00260-9.
PMID: 14624410BACKGROUNDJenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, Lapsley KG, Trautwein EA, Josse RG, Leiter LA, Connelly PW. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003 Jul 23;290(4):502-10. doi: 10.1001/jama.290.4.502.
PMID: 12876093BACKGROUNDJenkins DJ, Kendall CW, Faulkner DA, Nguyen T, Kemp T, Marchie A, Wong JM, de Souza R, Emam A, Vidgen E, Trautwein EA, Lapsley KG, Holmes C, Josse RG, Leiter LA, Connelly PW, Singer W. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr. 2006 Mar;83(3):582-91. doi: 10.1093/ajcn.83.3.582.
PMID: 16522904BACKGROUNDJenkins DJ, Jones PJ, Lamarche B, Kendall CW, Faulkner D, Cermakova L, Gigleux I, Ramprasath V, de Souza R, Ireland C, Patel D, Srichaikul K, Abdulnour S, Bashyam B, Collier C, Hoshizaki S, Josse RG, Leiter LA, Connelly PW, Frohlich J. Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA. 2011 Aug 24;306(8):831-9. doi: 10.1001/jama.2011.1202.
PMID: 21862744BACKGROUNDJenkins DJ, Chiavaroli L, Wong JM, Kendall C, Lewis GF, Vidgen E, Connelly PW, Leiter LA, Josse RG, Lamarche B. Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ. 2010 Dec 14;182(18):1961-7. doi: 10.1503/cmaj.092128. Epub 2010 Nov 1.
PMID: 21041432BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Sievenpiper, MD, PhD
University of Toronto
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 8, 2018
First Posted
May 23, 2018
Study Start
January 1, 2018
Primary Completion
August 1, 2018
Study Completion
October 1, 2018
Last Updated
May 23, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share
This is not applicable since there is no individual participant data.